Jerry D. Johnson

Array ( [id] => 19372328 [patent_doc_number] => RE050083 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-08-20 [patent_title] => URAT1 inhibitor and use thereof [patent_app_type] => reissue [patent_app_number] => 17/707795 [patent_app_country] => US [patent_app_date] => 2022-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11462 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19324206 [patent_doc_number] => RE050050 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-07-23 [patent_title] => Pyrimidinedione compounds [patent_app_type] => reissue [patent_app_number] => 17/699114 [patent_app_country] => US [patent_app_date] => 2022-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28538 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19119507 [patent_doc_number] => RE049934 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-04-23 [patent_title] => Inhibitors of cellular metabolic processes [patent_app_type] => reissue [patent_app_number] => 17/689209 [patent_app_country] => US [patent_app_date] => 2022-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79322 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18915260 [patent_doc_number] => RE049811 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-01-23 [patent_title] => Sphingosine kinase inhibitors [patent_app_type] => reissue [patent_app_number] => 17/688814 [patent_app_country] => US [patent_app_date] => 2022-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 30350 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17688814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19119504 [patent_doc_number] => RE049931 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-04-23 [patent_title] => [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds [patent_app_type] => reissue [patent_app_number] => 17/584147 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50142 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 430 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19058326 [patent_doc_number] => RE049880 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-03-26 [patent_title] => [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds [patent_app_type] => reissue [patent_app_number] => 17/584139 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50447 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19074670 [patent_doc_number] => RE049893 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-04-02 [patent_title] => [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds [patent_app_type] => reissue [patent_app_number] => 17/584155 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51109 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 431 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17368191 [patent_doc_number] => 20220023243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => COMPOSITIONS OF ABSCISIC ACID FOR ANIMAL HEALTH [patent_app_type] => utility [patent_app_number] => 17/495128 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495128 [rel_patent_id] =>[rel_patent_doc_number] =>)